BUSINESS● LOWAug 14 · Aug 14, 2026, 12:33 PM
VistaGen Therapeutics GAAP EPS of -$0.30 beats by $0.06, revenue of $1.48M beats by $1.31M
Seeking Alpha Tech
VistaGen Therapeutics reported GAAP Earnings Per Share (EPS) of -$0.30, beating expectations by $0.06, and revenue of $1.48 million, surpassing estimates by $1.31 million. This indicates better-than-expected financial results for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoGalleon Gold increases bought deal private placement of shares to $27MSeeking Alpha TechBUSINESS23m agoTech stocks had a nice oversold bounce on Monday. Earnings this week will determine if it's for realCNBC